Skip to content

Welcome to Discover Pharma! Today is : October 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Machine Learning

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Carterra and AstraZeneca target AI-driven drug discovery

    Carterra and AstraZeneca are collaborating to develop laboratory hardware and [...]

    October 12, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Insilico launches open consortium to assess AI drug discovery benchmarks

    Insilico Medicine has launched an open consortium and benchmark index [...]

    August 24, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Delivery & Formulation,Manufacturing & Supply Chain,Medical devices

    Germfree and Nuvai add AI monitoring to IV compounding

    Germfree and Nuvai Medical Technologies are partnering to integrate AI-powered [...]

    August 19, 2026
  • Digital & Data

    Qureight expands London operations to develop AI chest imaging model

    Qureight has opened a second UK site in London as [...]

    August 19, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    AI virtual screening tool boosts hit rate 100-fold on challenging drug targets

    An AI-driven virtual screening platform developed by Deep Origin has [...]

    August 6, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Latent Labs opens lab-validated AI drug design platform to researchers worldwide

    Latent Labs has launched its artificial intelligence-powered drug design platform [...]

    July 15, 2026
  • Digital & Data,Drug Discovery & Development

    Sygnature Discovery partners with DaltonTx to expand AI drug discovery capabilities

    Sygnature Discovery has entered into a strategic collaboration with AI [...]

    June 11, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Apoha raises $36M to expand molecular behaviour data platform

    London-based technology company Apoha has emerged from stealth with $36 [...]

    June 8, 2026
  • Biotech & Pharma Business,Digital & Data

    IMU Biosciences extends Series A to $53M to advance immune profiling platform

    IMU Biosciences has extended its Series A financing to more [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Quotient Sciences begins Phase 1 study of AI-designed drug formulation

    Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

    June 6, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • E2 secures FDA clearance for pulmonary embolism thrombectomy system
    Categories: Clinical & Regulatory, Medical devices
  • Carterra and AstraZeneca target AI-driven drug discovery
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Research & Development
  • Biopharma dealmaking outlook improves despite investor caution
    Categories: Biotech & Pharma Business, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top